{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:08:43Z","timestamp":1778623723369,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["10\/2021"],"award-info":[{"award-number":["10\/2021"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Fondazione per La Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["PEDEMO20G0"],"award-info":[{"award-number":["PEDEMO20G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BRODSK21I0"],"award-info":[{"award-number":["BRODSK21I0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["FARINH19I0"],"award-info":[{"award-number":["FARINH19I0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HARRIS21G0"],"award-info":[{"award-number":["HARRIS21G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04046\/2020"],"award-info":[{"award-number":["UIDP\/04046\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04046\/2020"],"award-info":[{"award-number":["UIDB\/04046\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcf.2022.12.010","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T07:29:17Z","timestamp":1672039757000},"page":"S1-S4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Fundamental and translational research in Cystic Fibrosis \u2013 why we still need it"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5467-1710","authenticated-orcid":false,"given":"Carlos M.","family":"Farinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6984-8486","authenticated-orcid":false,"given":"Jeffrey L.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5161-1720","authenticated-orcid":false,"given":"Nicoletta","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2022.12.010_bib0001","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1016\/j.febslet.2006.06.025","article-title":"Fundamental research is the basis for understanding and treatment of many human diseases","volume":"580","author":"Vance","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jcf.2022.12.010_bib0002","article-title":"The first metal based anticancer drug","volume":"88","author":"Cisplatin","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jcf.2022.12.010_bib0003","article-title":"Bortezomib for the treatment of multiple myeloma","volume":"4","author":"Scott","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2022.12.010_bib0004","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2022.12.010_bib0005","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2022.12.010_bib0006","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2022.12.010_bib0007","unstructured":"https:\/\/investors.vrtx.com\/news-releases\/news-release-details\/vertex-announces-fda-approvals-trikaftar."},{"key":"10.1016\/j.jcf.2022.12.010_bib0008","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcf.2021.07.004","article-title":"Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study","volume":"21","author":"Archangelidi","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.010_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2017.02.024","article-title":"Molecular Structure of the Human CFTR Ion Channel","volume":"169","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jcf.2022.12.010_bib0010","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1073\/pnas.1815287115","article-title":"Molecular structure of the ATP-bound, phosphorylated human CFTR","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2022.12.010_bib0011","article-title":"Structure basis of CFTR folding, function and pharmacology","author":"Hwang","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.010_bib0012","doi-asserted-by":"crossref","unstructured":"Ghigo A, DeSanti C, Hart M, Mitash N, Swiatecka-Urban A. Cell signaling and regulation of CFTR expression in cystic fibrosis cells in the era of high efficiency modulator therapy. 2023.","DOI":"10.1016\/j.jcf.2022.12.015"},{"key":"10.1016\/j.jcf.2022.12.010_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.690247","article-title":"Role of Protein Kinase A-Mediated Phosphorylation in CFTR Channel Activity Regulation","volume":"12","author":"Della Sala","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcf.2022.12.010_bib0014","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/BST20170469","article-title":"Non-coding RNA in cystic fibrosis","volume":"46","author":"Glasgow","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jcf.2022.12.010_bib0015","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ymthe.2020.02.001","article-title":"Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells","volume":"28","author":"De Santi","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcf.2022.12.010_bib0016","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fcell.2020.00058","article-title":"TGF-beta1 Augments the Apical Membrane Abundance of Lemur Tyrosine Kinase 2 to Inhibit CFTR-Mediated Chloride Transport in Human Bronchial Epithelia","volume":"8","author":"Cruz","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jcf.2022.12.010_bib0017","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1074\/jbc.M114.563742","article-title":"LMTK2-mediated Phosphorylation Regulates CFTR Endocytosis in Human Airway Epithelial Cells","volume":"289","author":"Luz","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcf.2022.12.010_bib0018","unstructured":"Hegyi P, Seidler U, Kunzelmann K. CFTR - beyond the airways. 2022."},{"key":"10.1016\/j.jcf.2022.12.010_bib0019","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPG.0000000000001788","article-title":"Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor: Case Series","volume":"66","author":"Carrion","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2022.12.010_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-pathol-022420-105133","article-title":"Animal Models and Their Role in Understanding the Pathophysiology of Cystic Fibrosis-Associated Gastrointestinal Lesions","volume":"16","author":"Gibson-Corley","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jcf.2022.12.010_bib0021","first-page":"23","article-title":"The NHE3 Inhibitor Tenapanor Prevents Intestinal Obstructions in CFTR-Deleted Mice","author":"Tan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcf.2022.12.010_bib0022","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-3476(71)80056-2","article-title":"Renal function in patients with cystic fibrosis","volume":"79","author":"Robson","year":"1971","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2022.12.010_bib0023","article-title":"Mucus aberrant properties in CF: Insights from cells and animal models","author":"Ehre","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.010_bib0024","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1164\/rccm.202008-3198OC","article-title":"Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia","volume":"203","author":"Okuda","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2022.12.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124863","article-title":"Mucus strands from submucosal glands initiate mucociliary transport of large particles","volume":"4","author":"Fischer","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcf.2022.12.010_bib0026","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1073\/pnas.1713539115","article-title":"Functional characterization of the mucus barrier on the Xenopus tropicalis skin surface","volume":"115","author":"Dubaissi","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2022.12.010_bib0027","article-title":"Restoring airway epithelial homeostasis in Cystic Fibrosis","author":"Cafora","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.010_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.979610","article-title":"Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models","volume":"13","author":"Cafora","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jcf.2022.12.010_bib0029","first-page":"11","article-title":"Surface Hydration Protects Cystic Fibrosis Airways from Infection by Restoring Junctional Networks","author":"Simonin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcf.2022.12.010_bib0030","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/ppul.25285","article-title":"Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype","volume":"56","author":"McGarry","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2022.12.010_bib0031","article-title":"Patient-derived cell models for personalized medicine approaches in cystic fibrosis","author":"Ramalho","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.010_bib0032","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/humu.23741","article-title":"Two CFTR mutations within codon 970 differently impact on the chloride channel functionality","volume":"40","author":"Amato","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jcf.2022.12.010_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102210","article-title":"Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics","volume":"64","author":"Cholon","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jcf.2022.12.010_bib0034","first-page":"23","article-title":"Assays of CFTR Function In Vitro, Ex Vivo and In Vivo","author":"Ramalho","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcf.2022.12.010_bib0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2022.12.010_bib0036","doi-asserted-by":"crossref","unstructured":"Allaire NE, Griesenbach U, Kerem B, Lueck JD, Stanleigh N, Oren YS. Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis. 2022.","DOI":"10.1016\/j.jcf.2022.12.016"},{"key":"10.1016\/j.jcf.2022.12.010_bib0037","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/hum.2020.142","article-title":"Gene Therapy for Respiratory Diseases: Progress and a Changing Context","volume":"31","author":"Alton","year":"2020","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcf.2022.12.010_bib0038","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jcf.2021.06.003","article-title":"Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation","volume":"20","author":"Oren","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.010_bib0039","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcf.2021.12.012","article-title":"Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation","volume":"21","author":"Oren","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.010_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.omtn.2022.04.033","article-title":"Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs","volume":"28","author":"Ko","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcf.2022.12.010_bib0041","article-title":"Development of novel therapeutics for all individuals with CF (the future goes on)","author":"Amaral","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.12.010_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167436","article-title":"Systems Approaches to Unravel Molecular Function: High-content siRNA Screen Identifies TMEM16A Traffic Regulators as Potential Drug Targets for Cystic Fibrosis","volume":"434","author":"Pinto","year":"2022","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jcf.2022.12.010_bib0043","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00439-016-1693-3","article-title":"Impact of gene editing on the study of cystic fibrosis","volume":"135","author":"Harrison","year":"2016","journal-title":"Hum Genet"},{"key":"10.1016\/j.jcf.2022.12.010_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102247","article-title":"CFTR RNA- and DNA-based therapies","volume":"65","author":"Harrison","year":"2022","journal-title":"Curr Opin Pharmacol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322014308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:14:32Z","timestamp":1778620472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322014308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"alternative-id":["S1569199322014308"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.12.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fundamental and translational research in Cystic Fibrosis \u2013 why we still need it","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}